title: [Vasoconstricting effect of endothelin. Interaction with atrial natriuretic factor, sodium nitroprusside, cicletanine and nifedipine].
abstract: The contractile properties of endothelin (ENDO) and its interactions with some putative antagonists were investigated in endothelium free ring of rat aorta. ENDO induced a slowly developing contraction which is only partially affected by sodium nitroprusside (10(-8) M - 10(-5) M) and to a lesser extend by the calcium antagonist nifedipine (10(-8) M - 10(-5) M). Atrial natriuretic factor (ANF) (10(-9) M - 10(-8) M), cicletanine (3.10(-5) M - 3.10(-4) M) and quercetin (10(-5) M - 10(-4) M) induced a dose dependent relaxation in ENDO precontracted preparations. ANF was less effective in inhibiting ENDO- than phenylephrine precontracted aorta. In addition, the ANF vasodilating effect upon ENDO contraction is potentiated by cicletanine (10(-4) M). The protein kinase C inhibitor phloretin, induced a dose-dependent relaxation (10(-5) M - 3.10(-4) M) in both ENDO and phorbol 12, 13-dibutyrate precontracted aorta. Whereas H7 (10(-5) M - 3.10(-4) M) an other protein kinase C inhibitor was only effective in ENDO-induced contraction. These data indicate that in isolated rat aorta, the contraction induced by ENDO does not mainly occur through membrane potential-dependent calcium channels. The vasoconstrictor mechanism of ENDO, which is different from the one triggered by phenylephrine could involve activation of protein kinase C.
authors.affiliation: Institut Henri-Beaufour, Le Plessis Robinson, France.
authors.forename: M
authors.initials: M
authors.lastname: Auguet
authors.forename: S
authors.initials: S
authors.lastname: Delaflotte
authors.forename: P E
authors.initials: PE
authors.lastname: Chabrier
authors.forename: P
authors.initials: P
authors.lastname: Braquet
mesh_terms: D000818:Animals; D001011:Aorta / Q000187:drug effects; D009320:Atrial Natriuretic Factor / Q000037:antagonists & inhibitors*; D004232:Diuretics / Q000037:antagonists & inhibitors*; D004305:Dose-Response Relationship, Drug; D016232:Endothelins; D005292:Ferricyanides; D008297:Male; D009543:Nifedipine / Q000037:antagonists & inhibitors*; D009599:Nitroprusside; D010455:Peptides / Q000494:pharmacology*; D011725:Pyridines; D051381:Rats; D011919:Rats, Inbred Strains
chemical_list: D004232:Diuretics; D016232:Endothelins; D005292:Ferricyanides; D010455:Peptides; D011725:Pyridines; D009599:Nitroprusside; D009320:Atrial Natriuretic Factor; C038068:cicletanine; D009543:Nifedipine
vernacular_title: Effet vasoconstricteur de l'endothéline. Interaction avec le facteur natriurétique atrial, le nitroprussiate de sodium, le ciclétanine et la nifédipine.